Xeris Pharmaceuticals | XERS - 资产

金融业

USD

USD 383.53M

现金及等价物

USD 111.04M

USD 13.66M

USD 240.31M

USD 109.57M

USD 257.65M

USD 16.77M

USD 25.09M

377

EPS每股收益

USD 0.05

股本和储备

USD 13.69M

USD 72.15M

债务利息支出

USD 7.15M

USD 1.16M

USD 220.34M

USD 849.7M

USD 11.08M

USD 69.03M

USD 16.77M

普通股股本

USD 166.22M

2.45K

USD 11.08M

USD 85.81M

销售和管理费用

USD 42.64M

USD 68.67M

贸易债权人

USD 3.08M

应收帐款人

USD 51.05M

	资产	更改		日
Celltrion	KRW 21.08T		530.63B	2025-09
Cspc Pharmaceutical	CNY 46.7B		695.56M	2025-12
Deva Holding AS	TRY 12.93B		1.83B	2023-09
Dianthus Therapeutics	USD 530.92M		46.52M	2025-12
Divis Laboratories Ltd	INR 181.51B		12.19B	2025-09
Eli Lilly	USD 112.48B		2.46B	2025-12
Kangmei Pharma	CNY 13.68B		38.19M	2025-09
Knight Therapeutics	CAD 1.05B		2.28M	2025-12
Laboratorios Farma	EUR 799.88M		99.95M	2023-12
Malin Corporation	EUR 198.5M		70.1M	2024-12
Medical Developments International	AUD 63.57M		2.83M	2025-12
Nektar Therapeutics	USD 280.41M		20.94M	2025-12
Neuren Pharmaceuticals	AUD 342.86M		11.61M	2025-12
Organigram Holdings	CAD 530.67M		31.54M	2025-12
Ovoca Bio	EUR 1.66M		9.75M	2025-06
Pacira	USD 1.26B		32.66M	2025-12
Perrigo	USD 8.54B		1.55B	2025-12
Pharma Mar	EUR 395.08M		53.42M	2025-12
Qiagen NV	USD 6.3B		257.54M	2025-12
Sartorius	EUR 9.87B		154.9M	2026-03
Sino Biopharmaceutical	CNY 74.89B		9.49B	2025-06
Supernus Pharmaceuticals	USD 1.45B		32.89M	2025-12
Tilray	USD 2.1B		15.95M	2025-09
Zealand Pharma A/S	15.95B		848.45M	2025-12
Zz Pientze Pharmaceu	CNY 17.48B		1.23B	2025-09